Royal Bank Of Canada Enveric Biosciences, Inc. Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$8.8 - $16.2 $70,162 - $129,162
7,973 Added 767.37%
9,012 $2,000
Q1 2022

May 16, 2022
BUY
$12.5 - $52.0 $12,987 - $54,028
1,039 New
1,039 $0

About Enveric Biosciences, Inc.

ENVB Quotes by TradingView
  • Ticker ENVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,078,270
  • Market Cap $686K
  • Description
  • Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for...
More about ENVB
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email